drugset
drugset / Trial / NCT03686501

D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562

NCT03686501 ↗

Phase 0 Completed 6 enrolled Invicro
NaSingle-groupOpen-labelOther

Summary

To assess the D1 receptor occupancy (D1 RO) in striatum after a single oral administration of PF-06412562.

Timeline

Start
2018-09-10
Primary completion
2019-03-28
Completion
2019-03-28

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-06412562 Unknown — Oral

Indications

No indication recorded.